Ketoamides were found to be used as inhibitors of cathepsin enzymes, particularly cathepsin K and cathepsin S. They have been developed as potential therapeutics for diseases like osteoporosis and cancer, where these enzymes play a role. The gene discussed is CTSS; the disease is osteoporosis.